Get unique expert insight into the impact and implications of Covid-19 on the Sustainable Development Goals with our podcast series.
For the benefit of healthcare professionals, medical researchers and the public, Elsevier has created a Novel Coronavirus Information Center with the latest medical and scientific information on COVID-19. The center has been set up since the start of the outbreak and is in English and Mandarin. Elsevier has provided full access to this content for PubMed Central and other public health databases, to accelerate the fight against coronavirus.
To assist health workers and researchers working under challenging conditions to bring this outbreak to a close, The Lancet has created a Coronavirus Resource Centre. This resource brings together new 2019 novel coronavirus disease (COVID-19) content from across The Lancet journals as it is published. All our COVID-19 content is free to access.
Elsevier recently launched a new free resource to aid healthcare workers on the front lines of managing the health crisis. The COVID-19 Healthcare Hub provides free access to toolkits, expert insights, research resources and guidelines to support their response
This Vaccine Toolkit provides the latest evidence-based information about vaccines approved for use to prevent COVID-19 infections. View vaccine drug monograph information as well as patient education resources.
Read more about how Elsevier is supporting your response to COVID-19
Nexis Newsdesk™ has produced COVID-19 and the Global Media Landscape, a Global Media and News Tracker with interactive charts that provide insight into the way coronavirus is developing across the global media landscape in near real time.
Coronovirus has been added to the LexisNexis Newsdesk® app, where all the news relating to the SDGs is available for free. All coronovirus news is available in the People section of the app. With the LexisNexis Human Rights app you can track and share every piece of SDG news across our unrivalled set of content to better understand progress toward those goals—and the work that still needs to be done.
Access curated news, emerging legislative issues and research materials to stay on top of changes related to COVID-19 and the law across the world and for specific jurisdictions. All resources in this site are free to access.
Law360 has launched a dedicated COVID-19 page containing breaking news, in-depth features and expert analysis and commentary on all things relating to COVID-19 and the law. Its comprehensive coverage and content illuminates how the global pandemic has impacted the legal industry and the practice of law, as well as the U.S. court system, federal agencies, industries, businesses and more.
To help U.S. attorneys manage the evolving COVID-19 crisis, Lexis Practice Advisor has developed a Coronavirus Resource Kit covering a wide range of topics across multiple practice areas. The Resource Kit addresses emerging issues and offers guidance relating to COVID-19 and the law. The Resource Kit’s content includes impact analysis on commercial deals and compliance, forms and guides for transactional and labor/employment contracts, regulatory tracking, and more.
LexisNexis Risk Solutions Health Care is committed to supporting the United States health response to the COVID-19 pandemic. By combining our unique data and analytics together with those of other industry stakeholders, we created the COVID-19 data set and interactive visualization in order to provide insights on at-risk populations and care capacity risks.
Cirium, which brings together aviation and air travel data and analytics, and is part of Risk & Business Analytics, has created a data visualisation on the impact of the virus on the aviation industry in China.